Schnog, J B <br/><br/>
Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.  [electronic resource] 

 -  Annals of hematology  May 2005 
 - 282-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0939-5555 
<br/><br/><label>Standard No.: </label>10.1007/s00277-004-0983-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia, Sickle Cell--blood<br/>Arginine--analogs & derivatives<br/>Female<br/>Hemoglobin, Sickle<br/>Humans<br/>Male<br/>Middle Aged<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Vascular Cell Adhesion Molecule-1--blood